Its not often that a medication becomes a household name across the world, and with such speed
[2] [3] Similarly, in the SURMOUNT trials for weight management, Zepbound's label reports gastrointestinal events as the most common adverse reactions, with nausea (24-30%), diarrhea (18-23%), vomiting (8-12%), and constipation (11-17%) occurring at somewhat higher rates than in diabetes trials
Thats good, seeing as PDE5 inhibitors can interact with heart conditions
others have a more modest response or stop treatment because of side effects
Understanding the Significance of Weight Management Excess weight comes with extensive health risks, including type 2 diabetes, heart disease, and even certain cancers